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Background: Several etiological reports have shown that chronic pain significantly interferes with sleep. Inadequate
sleep due to chronic pain may contribute to the stressful negative consequences of living with pain. However, the
neurophysiological mechanism by which chronic pain affects sleep-arousal patterns is as yet unknown. Although
serotonin (5-HT) was proposed to be responsible for sleep regulation, whether the activity of 5-HTergic neurons in
the dorsal raphe nucleus (DRN) is affected by chronic pain has been studied only infrequently. On the other hand,
the recent development of optogenetic tools has provided a valuable opportunity to regulate the activity in
genetically targeted neural populations with high spatial and temporal precision. In the present study, we
investigated whether chronic pain could induce sleep dysregulation while changing the activity of DRN-5-HTergic
neurons. Furthermore, we sought to physiologically activate the DRN with channelrhodopsin-2 (ChR2) to identify a
causal role for the DRN-5-HT system in promoting and maintaining wakefulness using optogenetics.
Results: We produced a sciatic nerve ligation model by tying a tight ligature around approximately one-third to
one-half the diameter of the sciatic nerve. In mice with nerve ligation, we confirmed an increase in wakefulness and
a decrease in non-rapid eye movement (NREM) sleep as monitored by electroencephalogram (EEG). Microinjection
of the retrograde tracer fluoro-gold (FG) into the prefrontal cortex (PFC) revealed several retrogradely labeled-cells
in the DRN. The key finding of the present study was that the levels of 5-HT released in the PFC by the electrical
stimulation of DRN neurons were significantly increased in mice with sciatic nerve ligation. Using optogenetic tools
in mice, we found a causal relationship among DRN neuron firing, cortical activity and sleep-to-wake transitions. In
particular, the activation of DRN-5-HTergic neurons produced a significant increase in wakefulness and a significant
decrease in NREM sleep. The duration of NREM sleep episodes was significantly decreased during photostimulation
in these mice.
Conclusions: These results suggest that neuropathic pain accelerates the activity of DRN-5-HTergic neurons.
Although further loss-of-function experiments are required, we hypothesize that this activation in DRN neurons
may, at least in part, correlate with sleep dysregulation under a neuropathic pain-like state.
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Figure 1 Effect of sciatic nerve ligation on thermal
hyperalgesia. A plantar test was performed at 7 days after sciatic
nerve ligation or sham operation. The statistical significance of
differences between groups was assessed by one-way ANOVA. Each
point represents the mean ± SEM (n = 8). *p < 0.05, ***p < 0.001
vs. sham.
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It is generally acknowledged that neuropathic pain is ex-
tremely difficult to treat, and a major factor that affects
outcomes is the presence of comorbidities, such as poor
sleep and mood disorders. In clinical studies, most pa-
tients began to have difficulties with sleep after they
began experiencing chronic pain [1,2]. However, the
neurophysiological mechanism by which chronic pain af-
fects sleep/arousal patterns is as yet unknown.
Serotonin (5-HT) was initially proposed to be respon-
sible for the initiation and maintenance of sleep [3]. The
firing rate of 5-HT-containing dorsal raphe nucleus (DRN)
neurons decreases during slow wave sleep relative to that
in wakefulness [4]. 5-HTergic neurons in the DRN fire ton-
ically and regularly at 3–5 Hz in wakefulness, fire less
during non–rapid eye movement (NREM) sleep, and are
silent during rapid eye movement (REM) sleep [5-9].
Therefore, the DRN is a 5-HTergic brainstem structure
that is thought to be important for promoting arousal.
Some neurons in the DRN respond to nociceptive
stimuli. Noxious stimulation caused changes in the elec-
trical activity of DRN neurons [10]. This concept was
confirmed by the 2-deoxy-D-glucose [11] and c-fos [12]
methods. However, whether the activity of 5-HTergic
neurons in the DRN is affected by chronic pain has been
studied only infrequently. In a previous study, 5-HT
transporter expression was shown to be significantly in-
creased in the DRN of sciatic nerve-ligated rats [13]. To
investigate the influence of neuropathic pain on DRN 5-
HTergic neurons, we performed an in vivo dialysis study.
We found that the 5-HT levels in the prefrontal cortex
(PFC) were significantly increased in nerve-ligated mice
compared to those in sham-operated mice after elec-
trical stimulation of the DRN.
New tools are needed to selectively manipulate the
discharge activities of the DRN in freely moving mice at
time-scales that are relevant to natural sleep-wake
events. The recent development of an optogenetic tool
[14,15] has provided a valuable opportunity to regulate
the activity in genetically targeted neural populations
with high spatial and temporal precision [16-19]. Opto-
genetics describes the now widespread use of microbial
opsins [20] or related tools, that can be activated by illu-
mination to manipulate cells even within intact tissue or
behaving animals [21-23]. We stimulated DRN neurons
with channelrhodopsin-2 (ChR2; a cation channel that
is sensitive to 473 nm blue light) [17]. We found that
mice showed an increase in the mean time of wakeful-
ness, and decreases in the mean time and duration of
NREM sleep, during optical stimulation of the DRN. To
our knowledge, no previous reports have described the
results obtained by stimulation of the DRN, which sug-
gest a potential mechanism for the sleep disturbance in-
duced by neuropathic pain.Results
Thermal hyperalgesia induced by sciatic nerve ligation
Sciatic nerve ligation caused a marked decrease in the
latency of paw withdrawal in response to thermal stimuli
only on the ipsilateral side (Figure 1: thermal hyperalge-
sia, p <0 .05 vs. sham group).
Changes in vigilance under a neuropathic pain-like state
with EEG/EMG
With this experimental model for neuropathic pain, we
investigated the changes in sleep patterns. Frontal cortical
activity and postural muscle tone, as monitored by EEG/
EMG, are useful for identifying sleep/wake abnormalities.
Vigilance was classified offline into 3 stages: wakefulness,
rapid eye movement sleep, and NREM sleep. Sciatic nerve
ligation for 7 days was associated with statistically significant
increases in wakefulness (Figure 2A: p < 0.001 vs. sham
group). Sciatic nerve ligation mice showed a statistically signifi-
cant decrease in NREM sleep (Figure 2B: p < 0.01 vs. sham
Figure 2 Change in the sleep/wake pattern as determined by EEG/EMG at 7 days after sciatic nerve ligation. The total mean times
(sec/h) in wakefulness (A), NREM sleep (B) and REM sleep (C) were determined by EEG/EMG recording for 24 hrs. Each point represents the
mean ± SEM (n = 11). Student’s t-test was performed. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with the sham group.
Ito et al. Molecular Brain 2013, 6:59 Page 3 of 10
http://www.molecularbrain.com/content/6/1/59group). No difference in REM sleep was found between sham
operation and sciatic nerve ligation for 7 days (Figure 2C).
Distribution of fluoro-gold(FG)-labeled cells following
microinjection in the PFC
To determine whether the DRN is linked to the PFC,
which would permit possible functional influences on
sleep and arousal neural circuits, we next investigated
whether there were any neuronal projections from the
DRN to the PFC using FG as a retrograde tracer. A sche-
matic illustration of the injection site in the PFC is shown
with a symbol (Figure 3A). Microinjection of FG into the
region of the unilateral PFC produced a well-restricted in-
jection site (Figure 3B). The DRN was shown to be located
in a coronal section of the mouse brain (Figure 3C). Tryp-
tophan hydroxylase 2 (Tph2)-labeled cells (Figure 3D, E)
or FG-labeled cell bodies (Figure 3F) were apparently de-
tected in the DRN after the microinjection of FG into the
PFC. The population of retrogradely labeled neurons in the
DRN also showed Tph2-immunoreactivity (Figure 3G).
Change in the increase in dialysate 5-HT levels in the PFC
induced by electrical stimulation of the DRN
To investigate whether sciatic nerve ligation induces the
hypersensitivity of DRN-PFC 5-HTergic neurons, we
tested the effect of repetitive stimulation with rectangu-
lar electrical pulses for 15 min. In an in vivo microdialy-
sis study, the dialysate 5-HT levels in the PFC of sciatic
nerve-ligated mice were significantly increased by elec-
trical stimulation (100 Hz, 150 μA) (Figure 4: p < 0.01 vs.
sham group). Under the same conditions, there was no
increase in the levels of dialysate 5-HT in the PFC of
sham-operated mice.Expression of optogenetic transgene in DRN and PFC
neurons of Tph2-ChR2 transgenic mice
We investigated the expression of ChR2-EYFP in the
DRN using immunohistochemistry. The DRN showed a
high density of EYFP-immunoreactivity in slices of the
mouse brainstem. To confirm the co-localization of
ChR2-EYFP and Tph2 in the DRN, double-labeling ex-
periments were performed. The results showed that
Tph2-immunoreactivity was mostly co-localized with
ChR2-EYFP (Figure 5).
Change in the dialysate levels of 5-HT induced by optical
stimulation in the mouse DRN
We confirmed that optical stimulation of the DRN af-
fected the levels of 5-HT secreted from nerve terminals
in the PFC. In an in vivo microdialysis study, the dialys-
ate 5-HT levels in the PFC of Tph2-ChR2 transgenic
mice were significantly increased by optical stimulation
of the DRN (p < 0.05: vs. No stimuli, Figure 6).
Optical stimulation of the DRN causes sleep-arousal
transitions
To determine whether neural activation in DRN-5-
HTergic neurons is necessary for interfering with sleep,
we tested the effect of long-term optical stimulation of
the DRN (8 mW, 20 Hz, 473 nm, blue light for 1 hr) on
the sleep-wake architecture during inactive periods. Tph2-
ChR2 transgenic mice showed a significant increase in
wakefulness (p < 0.01 vs. No stimuli) and a significant de-
crease in NREM sleep (p < 0.01 vs. No stimuli) during op-
tical stimulation, compared with no stimuli (Figure 7A).
The duration of NREM sleep episodes was significantly de-
creased during optical stimulation in these mice (Figure 7B:
Figure 3 Projection of 5-HT neurons from the dorsal raphe nucleus (DRN) to the prefrontal cortex (PFC) of mice. Schematic illustrations
of the injection site (symbols) in the PFC (A). The image shows the extent of FG diffusion at the injection site (B). Location of the DRN in a
coronal section of mouse brain (C). Tph2-immunoreactivity was noted in the DRN (D, E). Cells in the DR after the microinjection of FG into the
PFC (F). Double-labeling experiments showed that FG-positive cells overlapped Tph2-positive cells in the DRN (G). Scale bars = 50 μm
(B and D). Aq: aqueduct of the cerebrum.
Ito et al. Molecular Brain 2013, 6:59 Page 4 of 10
http://www.molecularbrain.com/content/6/1/59p < 0.01 vs. No stimuli). During optical stimulation, there
was a significant decrease in slow wave activity (0.5-4 Hz)
in Tph2-ChR2 transgenic mice (p < 0.05: vs. No stimuli,
Figure 7C).
Discussion
Sciatic nerve constriction was previously reported to in-
duce poor sleep quality in rats, particularly during the
first week with this condition [24]. In our present study,
we demonstrated that sciatic nerve-ligated mice exhibit
dysregulation of the sleep/arousal pattern. These find-
ings suggest that neuropathic pain induced by peripheral
nerve injury may lead to the development of insomnia.
We analyzed the neural circuit using the retrograde
tracer FG to investigate the nuclear origins of 5-HTergic
neurons. We injected FG into the PFC, which is associated
with sleep/arousal patterns [25]. FG-labeled cell bodies
were detected in the DRN, and Tph2-immunoreactivitywas revealed in a population of these labeled neurons. The
DRN is one of the raphe nuclei located in the midline of
the brainstem and is one of the largest 5-HTergic nuclei.
Immunohistochemical studies have reported that the
DRN contains as many as 9,200 5-HT neurons [26] or as
few as 4,000 [27] in mice. Neurons from the DRN provide
a substantial proportion of the 5-HT innervation to the
forebrain through their widespread projections [28].
In a previous study, 5-HT transporter expression was
shown to be significantly increased in the DRN of sciatic
nerve-ligated rats [13]. However, few studies have inves-
tigated the direct influence of neuropathic pain on DRN
5-HTergic neurons. Therefore, we performed an in vivo
microdialysis study to determine the activity of 5-HTergic
neurons from the DRN to the PFC under a neuropathic
pain-like state. The 5-HT level at the PFC was signifi-
cantly increased in nerve-ligated mice compared with that
in sham-operated mice after electrical stimulation of the
Figure 4 Change in the dialysate levels of 5-HT induced by
electrical stimulation in the mouse DRN at 7 days after sciatic
nerve ligation. To investigate the effect of electrical stimulation of
the DRN, we evaluated the dialysate 5-HT levels in the PFC in mice by
in vivo microdialysis. The mice were subjected to electrical stimulation,
sine-wave pulses (100 Hz, 150 μA), for 15 min. The data are expressed
as percentages of the corresponding baseline levels ± SEM (n = 4).
**p < 0.01 vs. sham. The X-axis shows different time points after
stimulation.
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ciated with an increased activity of 5-HTergic neurons
projecting from the DRN to the PFC.
Several areas in the brainstem and forebrain are im-
portant for modulation and expression of the sleep/wake
cycle. It is now well established that several neurotrans-
mitters and neuropeptides are involved in modulation of
the sleep/wake cycle. 5-HT has been known for many
years to play a role in the modulation of sleep. EarlyFigure 5 Specific expression of optogenetic transgenes in the DRN. R
column, red), EYFP immunoreactivity (center column, green) and merged im
mice. Top row, expression in the entire DRN (Scale bars, 50 μm); bottom rostudies suggested that 5-HT is necessary to achieve and
maintain behavioral sleep [3,29-31]. However, the 5-HT-
sleep connection was strongly contradicted by data on
the activity of the DRN, in that the activity of DRN neu-
rons was greatest during wakefulness, considerably lower
during NREM sleep, and completely abolished during
REM sleep [4-9]. Also, the cooling of raphe neurons in-
duced sleep [32,33]. Thus, it is still very controversial
how and where 5-HT participates in this modulation.
A major advantage of an optogenetic approach versus
traditional electrical stimulation [34] or pharmacological
manipulation [35-38] is its ability to elicit neural activity
at specifically defined temporal windows with minimal
disturbance to the animal [39]. Electrical stimulation has
a high probability of exerting excessive effects on other
neurons and glial cells around the target, since the DRN
in mice is quite small. On the other hand, the stimula-
tion of DRN neurons using the local microinjection of
pharmacological agents affects circumventricular organs
due to the anatomical location of the DRN. In fact, it is
possible for the injected agents to leak into the cerebral
ventricles. The optogenetic gain-of-function approach
has achieved not only regiospecific effects but also effi-
cient genetic targeting of 5-HTergic neurons, which may
explain the difference between the results of the optoge-
netic approach and those of other studies. In the present
study, we therefore performed a system function analysis
of DRN-5-HTergic neurons using transgenic mice that
express ChR2 in neurons containing Tph2. We first per-
formed an immunohistochemistry study to evaluate the
expression of ChR2 in 5-HTergic neurons in the DRN.
Although our immunostaining experiment on DRN neu-
rons in acute brainstem slices showed ChR2 expressionepresentative photomicrographs depicting Tph2 immunoreactivity (left
ages (right column) in the DRN obtained from Tph2-ChR2 transgenic
w, individual neurons (Scale bars, 10 μm).
Figure 6 Change in the dialysate levels of 5-HT induced by
optical stimulation in the mouse DRN. Extracellular 5-HT content
in the PFC during optical stimulation at 20 Hz in the DRN. Values are
shown as the means with SEM(n = 3). *p < 0.05 vs. No stimuli.
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these tools modulate neural activity as precisely in vivo.
Therefore, we performed an in vivo microdialysis study
to evaluate the levels of 5-HT released in the PFC during
optical stimulation of the DRN, which increases the 5-
HT level. Using this strategy, we confirmed the proper
functioning of ChR2 expressed in the DRN. Next, we
evaluated changes in the sleep and arousal pattern using
EEG and EMG during optical stimulation of the DRN
expressing ChR2. With optical stimulation, the total dur-
ation of wakefulness increased and that of NREM sleep
decreased. These results suggest that the activation ofFigure 7 Changes in the sleep/wake pattern induced by optical stimu
relative EEG power of NREM (C) were determined by EEG/EMG recordings
and **p < 0.01 vs. No stimuli.DRN 5-HTergic neurons facilitates awakening. In con-
trast, activation of the DRN caused a decrease in the
duration of the NREM sleep stage. Therefore, we con-
clude that the DRN is sufficient to promote sleep-to-
wake transitions. Furthermore, in the power density of
the EEG analysis, there was a significant decrease in
slow wave activity during optical stimulation. This obser-
vation indicates that the activation of DRN-5-HTergic
neurons has the potential to change the quality of sleep.
The functional role of 5-HT neurons in relation to the
sleep/wake cycle may not only be confined to the DRN,
but is also evident in other 5-HT sources of the brain-
stem [40], such as the median raphe nucleus, which
gives rise to the majority of serotonergic ascending fibers
into the forebrain [41-43]. Thus, further experiments on
the influence of other 5-HT sources are needed to better
understand the role of 5-HTergic networks in regulating
the sleep-wake pattern under both physiological and
chronic pain conditions.
Based on genetic [44-48] and pharmacological experi-
ments [36,49-52], it is accepted that 5-HT functions
predominantly to promote wakefulness. Although we
demonstrated that both neuropathic pain and the specific
activation of DRN-5HTergic neurons lead to a decrease in
NREM sleep and no difference of REM sleep, the causal
mechanism of this difference between REM and NREM is
still unclear. In addition, it is unclear whether the
enhanced release of 5-HT in the PFC is essential for
neuropathic pain-induced sleep dysregulation, since our
preliminary data show that no significant increase in the
basal level of released 5-HT was likely to be seen without
electrical stimulation when the sleep/wake pattern waslation in the mouse DRN. Mean time (A), mean duration (B) and
for 3 hr. Values are shown as the means with SEM (n = 3). *p < 0.05
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why we did not observe an increase at this stage may be
because under pathophysiological conditions, chronic pain
may gradually increase the basal release of 5-HT in the
PFC and affect the sleep/wake pattern, but constantly this
will return to the normal level. Although we cannot com-
pletely exclude the possibility that the enhanced release of
5-HT in the PFC is not essential for chronic pain-induced
abnormal sleep, we propose here that this activation in
DRN neurons may, at least in part, be associated with
sleep dysregulation under a neuropathic pain-like state.
Furthermore, we also believe that other nuclei, such as the
noradrenergic locus ceruleus nucleus [53], histaminergic
tuberomammilary nucleus [54], cholinergic pedunculo-
pontine nucleus and lateral tegmental nucleus [55,56], as
well as multiple cell types in the basal forebrain [57], may
also presumably contribute to sleep-to-wake transitions.
Conclusion
In conclusion, we have demonstrated that neuropathic
pain leads to sleep dysregulation, in parallel with the in-
creased activity of DRN 5-HTergic neurons. Using an
optogenetic approach, we found that the activation of
DRN neurons facilitates sleep-to-wake transitions, which
results in the dysregulation of sleep. Although further
clarification is needed, we propose that acceleration of
the activity of DRN-5-HTergic neurons may at least




The present study was conducted in accordance with
the Guiding Principles for the Care and Use of Labora-
tory Animals at Hoshi University, as adopted by the
Committee on Animal Research of Hoshi University
(Tokyo, Japan). Male C57BL/6 J mice (8 weeks; Tokyo
Laboratory Animals Science, Tokyo, Japan) and Tph2-
ChR2 transgenic mice (B6; SJL-TG (Tph2-COP*H134R/
EYFP) 5Gfng/J) [16] were used in this study. Tph2 is the
rate-limiting enzyme in the synthesis of 5-HT in the
central nervous system. The transgene ChR2 (H134R)-
EYFP was constructed into the ATG (initiation codon)
site of the first exon of Tph2. Animals were housed in a
room maintained at 23 ± 1°C with a 12-hr light–dark
cycle. Food and water were available ad libitum. Every
effort was made to minimize the numbers and any suffer-
ing of animals used in the following experiments. Each
animal was used only once.
Neuropathic pain model
Mice were anesthetized with 3% isoflurane. We pro-
duced a partial sciatic nerve ligation model as described
previously [58]. In brief, the sciatic nerve on the rightside (ipsilateral side) was tied by a tight ligature with
8–0 silk suture around approximately one-half its diam-
eter under a light microscope (SD30; Olympus, Tokyo,
Japan). In sham-operated mice, the nerve was only ex-
posed without ligation.
Measurement of thermal thresholds
C57BL/6 J mice were used for the measurement of ther-
mal thresholds. To assess the sensitivity to thermal
stimulation, the right plantar surface of mice was tested
individually by using a well-focused, radiant heat light
source (model 33 Analgesia Meter; IITC/Life Science In-
struments, California, USA). The intensity of the thermal
stimulus was adjusted to achieve an average baseline
paw-withdrawal latency of approximately 8–10 sec in
naive mice. The paw-withdrawal latency was determined
as the average of three measurements per paw. Only
quick hind paw movements (with or without licking of
hind paws) away from the stimulus were considered to
be a withdrawal response. Paw movements associated
with locomotion or weight-shifting were not counted as
a response. The paws were measured alternating be-
tween the left and right with an interval of more than
3 min between measurements. Before the behavioral re-
sponses to the thermal stimulus were tested, mice were
habituated for at least 1 hr in a clear acrylic cylinder
(15 cm high and 8 cm in diameter). Under these condi-
tions, the latency of paw withdrawal in response to the
thermal stimulus was tested. The data represent the
average value for the withdrawal latency of the right
hind paw.
EEG and EMG recordings
Under 3% isoflurane anesthesia, mice were implanted
with EEG and EMG electrodes for polysomnographic re-
cordings (Pinnacle Technology, Oregon, USA). Briefly,
to monitor EEG signals, two stainless steel EEG record-
ing screws were positioned 1 mm anterior to the bregma
or lambda, both 1.5 mm lateral to the midline. EMG activ-
ity was monitored by stainless steel, Teflon-coated wires
placed bilaterally into both trapezius muscles. Sleep–wake
states were then monitored for a period of 24 hr at 2 days
after placement of the EEG recording screws, encompass-
ing both the baseline and the experimental day. The EEG/
EMG signals were amplified, filtered (EEG, 0.5–30 Hz;
EMG, 20–200 Hz), and digitized at a sampling rate of
128 Hz. The collected data were analyzed by software
(SLEEPSIGN; Kissei Comtec, Nagano, Japan). Vigilance
was automatically classified off-line under 5-sec epochs
into three stages, i.e., wakefulness, REM and NREM sleep,
by SLEEPSIGN according to the standard criteria. As a
final step, defined sleep–wake stages were examined visu-
ally and corrected, if necessary. For each epoch, the EEG
power density in the δwave (0.75–4.0 Hz) and θwave
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played on a PC monitor. Three vigilance states -(1) waking
(high EMG and low EEG amplitude and high θwave activ-
ity concomitant with the highest EMG values), (2) NREM
sleep (low EMG and high EEG amplitude, high δwave ac-
tivity), and (3) REM sleep (low EMG and low EEG ampli-
tude, high θwave activity)- were determined for 5-sec
epochs, and the scores were entered into a computer via a
keyboard. EEG and EMG activities were monitored at 7
days after sciatic nerve ligation.
Retrograde tracing study
First, C57BL/6 J mice were deeply anesthetized with 3%
isoflurane. The anesthetized animals were placed in a
stereotaxic apparatus. The skull was exposed, and a hole
was drilled through the skull over the dorsolateral PFC,
according to an atlas [59]. Micropipettes were filled with
retrograde tracer, FG solution (Fluorochrome, Colorado,
USA; 4% solution in saline), and 0.2 μl of the tracer was
injected over 30 sec. The micropipette was left in place
for 1 min after injection was complete to avoid leakage
of the tracer along the pipette track, and then withdrawn
from the brain. Two days after the injections, animals
were perfused with formalin. The distribution of gold-
emitting FG retrogradely labeled neurons and FG injec-
tion sites were detected using a microscope (BX-60;
Olympus, Tokyo, Japan).
Electrical stimulation
At the start of the surgical procedures, C57BL/6 J mice
were anesthetized with 3% isoflurane and placed in a
small animal stereotaxic apparatus. Mice underwent
surgical implantation of a bipolar concentric electrode
(MS3033SPCE; Bio Research, Nagoya, Japan) at least 1
day before the experiments. The electrode was placed in
the DRN (from the bregma: anteroposterior, -4.9 mm;
mediolateral, + 0 mm; dorsoventral, -3.4 mm) and fixed
to the skull with quick self-curing acrylic resin. Electrical
stimulation was controlled by an electronic stimulator
(Nihon Kohden, Tokyo, Japan) to generate repetitive
rectangular pulses (duration, 500 μs; intensity, 150 μA;
frequency, 100 Hz).
In vivo microdialysis and high-performance liquid
chromatography
Under anesthesia with 3% isoflurane, mice were placed
in a stereotaxic apparatus and a microdialysis probe
(D-1-6-01; Eicom, Tokyo, Japan) was implanted directly
into the PFC (from the bregma: anteroposterior, +1.5 mm;
mediolateral, + 0.5 mm; dorsoventral, -3.7 mm) accord-
ing to an atlas of the mouse brain [59]. The probe was
fixed to the cranial bone with quick self-curing acrylic
resin. More than 24 hr after surgery, the mice were
placed in experimental cages. The probes were perfusedcontinuously (1 μl/min) with artificial cerebrospinal fluid:
0.9 mM MgCl2, 147.0 mM NaCl, 4.0 mM KCl, and
1.2 mM CaCl2. Outflow fractions were collected every
15 min. After more than four baseline fractions were col-
lected, mice were given electrical stimulation or optical
stimulation for 15 min. Dialysis samples were collected for
1 hr after electrical stimulation or optical stimulation and
analyzed by high-performance liquid chromatography
with electrochemical detection (HTEC-500; Eicom, Tokyo,
Japan). 5-HT was separated by column chromatography
and identified and quantified by the use of a standard
(Sigma Aldrich, Missouri, USA).
Immunohistochemistry
Tph2-ChR2 transgenic mice were deeply anesthetized by
the inhalation of 3% isoflurane with oxygen and perfusion-
fixed with 4% paraformaldehyde in 0.1 M phosphate-
buffered saline (pH 7.4). After perfusion, the brain was
quickly removed and thick coronal sections of the frontal
cortex including the cingulate cortex or the brainstem in-
cluding the DRN were rapidly dissected and fixed in 4%
paraformaldehyde for 2 hr. They were then permeated
with 20% sucrose in 0.1 M phosphate-buffered saline for 1
day and 30% sucrose in 0.1 M phosphate-buffered saline
for 2 days with agitation. The brain sections were finally
frozen in an embedding compound (Sakura Finetechnical,
Tokyo, Japan) on isopentane using liquid nitrogen and
stored at −30°C. Transverse sections were cut with a cryo-
stat (Leica CM1510; Leica Microsystems, Heidelberg,
Germany) at a thickness of 8 μm and thaw-mounted on
poly-L-lysine-coated glass slides. Brain sections including
PFC or DRN were incubated in blocking solution, 3%
normal goat serum (Vector Laboratories, California, USA)
in 0.01 M phosphate-buffered saline, for 1 hr at room
temperature, and then incubated for 48 hr at 4°C with pri-
mary antibodies diluted in 3% normal goat serum: anti-
Tph2 (mouse monoclonal.; Sigma Aldrich, Missouri, USA)
and anti-green fluorescent protein (GFP; rabbit polyclonal;
Molecular Probes, Oregon, USA) for double-staining. The
antibody was then rinsed with phosphate-buffered saline
and incubated with an appropriate secondary antibody
conjugated with Alexa™ 546 (Molecular Probes, Oregon,
USA) for 2 hr at room temperature. Fluorescence of
immunolabelling was detected using a light microscope
(BX61; Olympus, Tokyo, Japan) and digitized images.
Optical stimulation
At the start of the surgical procedures, Tph2-ChR2 trans-
genic mice were anesthetized with 3% isoflurane and
placed on a small animal stereotaxic apparatus. Mice
underwent the surgical implantation of an 8 mm unilateral
cannula (EIM-300; Eicom, Tokyo, Japan) at least 1 day be-
fore the experiments. The cannula was placed above the
DRN and fixed to the skull with quick self-curing acrylic
Ito et al. Molecular Brain 2013, 6:59 Page 9 of 10
http://www.molecularbrain.com/content/6/1/59resin. An optical fiber (500 μm diameter; Lucir, Osaka,
Japan) was placed inside the implanted cannula at least
2 hr before the experiments. The light source was a
473 nm blue laser (COME2-LB473 model; Lucir, Osaka,
Japan) controlled by an electronic stimulator (Nihon
Kohden, Tokyo, Japan) to generate tonic light pulses (dur-
ation, 10 ms; frequency, 20 Hz; intensity, 9 mW). The
power output was measured at the tip of the fiber with a
NOVA light meter (Ophir, Saitama, Japan) when the laser
was activated in continuous mode.
Statistical analysis
Data are expressed as the mean with SEM. The statis-
tical significance of differences between the groups was
assessed with one-way ANOVA or two-way ANOVA
followed by the Bonferroni multiple comparisons test or
unpaired-Student’s t test as appropriate. All statistical
analyses were performed with Prism version 5.0a or 6.0b
(GraphPad Software, California, USA).
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